Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma.
Li XY, Wu JC, Liu P, Li ZJ, Wang Y, Chen BY, Hu CL, Fei MY, Yu PC, Jiang YL, Xu CH, Chang BH, Chen XC, Zong LJ, Zhang JY, Fang Y, Sun XJ, Xue K, Wang L, Chen SB, Jiang SY, Gui AL, Yang L, Gu JJ, Yu BH, Zhang QL, Wang L.
Li XY, et al. Among authors: yu bh, yu pc.
Leukemia. 2023 Jan;37(1):164-177. doi: 10.1038/s41375-022-01747-2. Epub 2022 Nov 9.
Leukemia. 2023.
PMID: 36352191
Free PMC article.